Moderna’s shares rose 11.94% over the past week. The supplied facts don’t identify a company-specific reason for the gain.
Moderna (NASDAQ:MRNA) also rose 6.69% on the latest day, closing at US$244.76. The listed headlines cover other companies and the broader healthcare sector, but none confirms a Moderna announcement or filing behind the move. The cause can’t be established from the information provided.
Investor takeaway: The weekly gain is clear, but its cause is not.
Advertisement
Moderna Inc
MRNA.US
MRNA.US
Moderna Inc
WealthAwesomeMarket cap
$96.65B
52W high
$243.98
52W low
$22.28
1W change
+11.94%
Beta
1.09
Analyst Price Targets
Based on 23 analysts covering MRNA · as of Oct 21, 2026
Wall Street analysts forecast MRNA stock price to fall 46.6% over the next 12 months.
Consensus
Hold3.13 / 5.00
Avg. Target
C$129.22
-46.6% Upside
Previously C$123.61 on Oct 19, 2026
Current Price
C$242.08
Last close
Analyst Breakdown (23 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRNA's historical volatility
30-Day Vol
82.4%
Annualized
90-Day Vol
194.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$289.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$256.93 | C$193.32 – C$341.47 |
| 60 trading days | C$272.68 | C$182.37 – C$407.73 |
| 90 trading days | C$289.41 | C$176.82 – C$473.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Moderna gained 11.94% in one week
Latest trading volume was 3,387,388 shares. The supplied figures list a 20-day average of 18,234,242 shares and a volume ratio of 0.92 times that average.
Bull case
The shares rose 11.94% over the week and 6.69% on the latest day, closing at US$244.76. They were also up 57.15% over the past month, according to the supplied figures.
Bear case
The available information doesn’t identify a company-specific catalyst. Latest reported volume was below the stated 20-day average.
What happened: a 11.94% weekly gain, with no confirmed company catalyst
Moderna’s shares rose 11.94% over one week, but the supplied facts don’t say what triggered the gain. The listed headlines cover the healthcare sector and other companies, with no confirmed Moderna-specific announcement. The weekly change alone doesn’t show whether company news, broader market activity or another factor drove the move. See the MRNA.US stock page for listed market information.
Advertisement
What the numbers show: US$244.76 close and below-average volume
Moderna closed at US$244.76. The supplied performance figures show a 6.69% daily gain and a 57.15% gain over one month. Latest volume was 3,387,388 shares, compared with a stated 20-day average of 18,234,242; the reported volume ratio was 0.92 times that average.
The supplied 52-week range is US$22.28 to US$243.98, putting the stated close slightly above its upper end. The information doesn’t explain the difference, so both figures are presented as reported. Moderna’s market capitalization was about US$96.6 billion, and its reported trailing EPS was negative US$7.98. More figures are available on the Moderna stock page.
What to watch next: a confirmed explanation for the move
The main unanswered question is whether a company-specific development explains the weekly gain. The supplied headlines don’t identify one, and list no Moderna filing, earnings release or other company event. The volume figures also don’t show trading above the stated 20-day average. Until a catalyst is confirmed, the gain can be reported but not attributed to a particular development.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
